Showing results (151-160 of 253) with videos related to
Sort By:
Pageof 26
The Biochemical Journal|April 1, 1986
The action of islet activating protein (pertussis toxin) on insulin's ability to inhibit adenylate cyclase and activate cyclic AMP phosphodiesterases in hepatocytesC M Heyworth, A M Grey, S R Wilson, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 27, 1999
Fine specificity and MHC restriction of trinitrophenyl-specific CTLA Franco, T Yokoyama, D Huynh, et al.The Journal of Clinical Investigation|February 1, 1976
Antigen heterogeneity of human B and T lymphocytesE M Rabellino, H M Grey, S LaForge, et al.Cell|September 10, 1993
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 moleculesJ Ruppert, J Sidney, E Celis, et al.Pediatric Diabetes|April 24, 2007
Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes, P Zeitler, L Epstein, et al.Teaching and Learning in Medicine|July 31, 2001
Reinforcement of occupational history taking: a success storyE Storey, S Thal, C Johnson, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1992
Effect of pH on MHC class II-peptide interactionsA Sette, S Southwood, D O'Sullivan, et al.Ophthalmic Surgery|May 1, 1994
Embryonal rhabdomyosarcoma of the orbit in a 35-year-old manN Mamalis, A M Grey, J S Good, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1989
Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structuresA Sette, A Lamont, S Buus, et al.Leukemia Research|December 11, 1997
Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemiaM Grey, A G Borg, P Wood, et al.Pageof 26